Evidence-based Mobile Medical Applications in Diabetes

Endocrinology and Metabolism Clinics of North America

Volumn 45, Issue 4, 2016, Pages 943-965

  Drincic, Andjela ^a   Prahalad, Priya ^b   Greenwood, Deborah ^c   Klonoff, David C ^d  

^a Nebraska Medicine   (United States)

^b STANFORD UNIVERSITY   (United States)

^c SUTTER HEALTH   (United States)

^d DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

Applications; Diabetes; Glucose; Medical; mHealth; Mobile; Telemedicine

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; DEVICE SAFETY; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN TREATMENT; MOBILE APPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELF CARE; SMARTPHONE; SOFTWARE DESIGN; EUROPEAN UNION; UNITED STATES;

DIABETES MELLITUS; EUROPEAN UNION; EVIDENCE-BASED MEDICINE; HUMANS; MOBILE APPLICATIONS; UNITED STATES;

EID: 84992221642     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2016.06.001     Document Type: Review

References (31)

1. 1 Institute of Medicine, Crossing the quality chiasm: a new health system for the 21st century. 2001, National Academy Press, Washington, DC.
2. 2 Klonoff, D.C., The current status of mHealth for diabetes: will it be the next big thing?. J Diabetes Sci Technol 7:3 (2013), 749–758.
3. 3 El-Gayar, O., Timsina, P., Nawar, N., et al. Mobile applications for diabetes self-management: status and potential. J Diabetes Sci Technol 7:1 (2013), 247–262.
4. 4 Arnhold, M., Quade, M., Kirch, W., et al. Mobile applications for diabetics: a systematic review and expert-based usability evaluation considering the special requirements of diabetes patients age 50 years or older. J Med Internet Res, 16(4), 2014, e104.
5. 5 Silva, B., Rodriguez, J., de la Torre Díez, I., et al. Mobile-health: a review of current state in 2015. J Biomed Inform 56 (2015), 265–272.
6. 6 Sheehy, S., Cohen, G., Owen, K.R., Self-management of diabetes in children and young adults using technology and smartphone applications. Curr Diabetes Rev 10:5 (2014), 298–301.
7. 7 mHealth, 2016, University of Florida Diabetes Institute Available at: http://diabetes.ufl.edu/my-diabetes/diabetes-resources/diabetes-apps/ Accessed March 31, 2016.
8. 8 Quinn, C., Khokhar, B., Weed, K., et al. Older adult self-efficacy study of mobile phone diabetes management. Diabetes Technol Ther 17:7 (2015), 455–461.
9. 9 Quinn, C., Shardell, M., Terrin, M., et al. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care 34:9 (2011), 1934–1942.
10. 10 Charpentier, G., Benhamou, P., Dardari, D., et al. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care 34:3 (2011), 533–539.
11. 11 Franc, S., Borot, S., Ronsin, O., et al. Telemedicine and type 1 diabetes: Is technology per se sufficient to improve glycaemic control?. Diabetes Metab 40:1 (2014), 61–66.
12. 12 Franc, S., Dardari, D., Biedzinski, M., et al. Type 1 diabetes: dealing with physical activity. Diabetes Metab 38:5 (2012), 466–469.
13. 13 Skrovseth, S., Arsand, E., Godtliebsen, F., et al. Data-driven personalized feedback to patients with type 1 diabetes: a randomized trial. Diabetes Technol Ther 17:7 (2015), 482–489.
14. 14 Rossi, M., Nicolucci, A., Bartolo, P., et al. Diabetes interactive diary: a new telemedicine system enabling flexible diet and insulin therapy while improving quality of life an open-label, international, multicenter, randomized study. Diabetes Care 33:1 (2010), 109–115.
15. 15 Rossi, M., Nicolucci, A., Pellegrini, F., et al. Impact of the “diabetes interactive diary” telemedicine system on metabolic control, risk of hypoglycemia, and quality of life: a randomized clinical trial in type 1 diabetes. Diabetes Technol Ther 15:8 (2013), 670–679.
16. 16 Barnard, K., Parkin, C., Young, A., et al. Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections. J Diabetes Sci Technol 6:1 (2012), 144–149.
17. 17 Ziegler, R., Cavan, D., Cranston, I., et al. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial. Diabetes Care 36:11 (2013), 3613–3619.
18. 18 Bergenstal, R., Bashan, E., McShane, M., et al. Can a tool that automates insulin titration be a key to diabetes management?. Diabetes Technol Ther 14:8 (2012), 675–682.
19. 19 Sussman, A., Taylor, E., Patel, M., et al. Performance of a glucose meter with a built-in automated bolus calculator versus manual bolus calculation in insulin-using subjects. J Diabetes Sci Technol 6:2 (2012), 339–344.
20. 20 Niel, J.V., Geelhoed-Duijvestijn, P.H., on behalf of the Dutch Insulinx Study Group. Use of a smart glucose monitoring system to guide insulin dosing in patients with diabetes in regular clinical practice. J Diabetes Sci Technol 8:1 (2014), 188–189.
21. 21 Javitt, J.C., Reese, C.S., Derrick, M.K., Deployment of an mHealth patient monitoring solution for diabetes—improved glucose monitoring leads to reduction in medical expenditure. US Endocrinol 9:2 (2013), 119–123.
22. 22 Iyer A. Mobile prescription therapy evolving mHealth from mobile to mainstream. 2014. Available at: http://www.himss.org/ResourceLibrary/GenResourceDetail.aspx?ItemNumber=30696. Accessed March 31, 2016.
23. 23 Comstock J. Voluntis raises $29M to bring diabetes app to US. 2014. Available at: http://mobihealthnews.com/32499/voluntis-raises-29m-to-bring-diabetes-app-to-us. Accessed March 31, 2016.
24. 24 BusinessWire. Study of Glytec's Glucommander™ in an outpatient setting indicates dramatic A1C reductions. 2015. Available at: http://www.businesswire.com/news/home/20151103006391/en/Study-Glytec%E2%80%99s-Glucommander%E2%84%A2-Outpatient-Setting-Dramatic-A1C. Accessed March 31, 2016.
25. 25 Greenwood, D.A., Young, H.M., Quinn, C.C., Telehealth remote monitoring systematic review: structured self-monitoring of blood glucose and impact on A1C. J Diabetes Sci Technol 8:2 (2014), 378–389.
26. 26 US Department of Health and Human Services. Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for industry diabetes mellitus: developing drugs and therapeutic biologics for treatment and prevention. Clinical/Medical. 2008. Available at: http://www.fda.gov/downloads/Drugs/.../Guidances/ucm071624.pdf Accessed March 22, 2016.
27. 27 Anderson M. Technology device ownership. 2015. Available at: http://www.pewinternet.org/2015/10/29/technology-device-ownership-2015/. Accessed March 31, 2016.
28. 28 Anderson M. The demographics of device ownership. Available at: http://www.pewinternet.org/2015/10/29/the-demographics-of-device-ownership/. Accessed March 31, 2016.
29. 29 U.S. Department of Health and Human Services Food and Drug Administration. Mobile Medical Applications: guidance for industry and Food and Drug Administration staff. Available at: http://www.fda.gov/downloads/UCM263366.pdf. Accessed March 31, 2016.
30. 30 Greenwood, D.A., Blozis, S.A., Young, H.M., et al. Overcoming clinical inertia: a randomized clinical trial of a telehealth remote monitoring intervention using paired glucose testing in adults with type 2 diabetes. J Med Internet Res, 17(7), 2015, e178.
31. 31 Gee, P.M., Greenwood, D.A., Paterniti, D.A., et al. The eHealth enhanced chronic care model: a theory derivation approach. J Med Internet Res, 17(4), 2015, e86.